They may be considered as part of dual or triple therapy when specific criteria are met, including BMI thresholds (35 kg/m or 32.5 kg/m in certain ethnic groups) and when weight loss would benefit other obesity-related comorbidities
Summary: GLP-1 receptor agonists can generally be used safely in patients with Hashimoto's disease when thyroid function is well-controlled with levothyroxine and appropriate monitoring is in place
Approximately 25% of total weight lost on tirzepatide was lean mass (SURMOUNT-1 DXA substudy), and in semaglutide trials, that proportion may reach up to 40% (STEP 1 DXA subset)
Lastly, Ozempic reduces appetite and promotes a feeling of fullness, which is highly effective for enhancing weight loss efforts
HomeShopAdvance NutritionRelumins Advance White 1650mg 15x Glutathione Complex New version with Hyaluronic Acid for powerful anti-aging benefits
However, the safety and efficacy of these combinations may not be well-documented, raising concerns